Cameron Marlow

451 total citations
17 papers, 362 citations indexed

About

Cameron Marlow is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Cameron Marlow has authored 17 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 9 papers in Molecular Biology and 3 papers in Surgery. Recurrent topics in Cameron Marlow's work include Prostate Cancer Treatment and Research (10 papers), Prostate Cancer Diagnosis and Treatment (8 papers) and Molecular Biology Techniques and Applications (5 papers). Cameron Marlow is often cited by papers focused on Prostate Cancer Treatment and Research (10 papers), Prostate Cancer Diagnosis and Treatment (8 papers) and Molecular Biology Techniques and Applications (5 papers). Cameron Marlow collaborates with scholars based in United States, United Kingdom and Netherlands. Cameron Marlow's co-authors include Robert W. Veltri, Alan W. Partin, Sumit Isharwal, Danil V. Makarov, Jonathan I. Epstein, Michael Craig Miller, Patricia Landis, Lori J. Sokoll, Edwin K. Wiredu and F V Flynn and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and The Journal of Urology.

In The Last Decade

Cameron Marlow

16 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cameron Marlow United States 12 162 113 49 42 40 17 362
Sergio González Chile 10 113 0.7× 191 1.7× 11 0.2× 141 3.4× 84 2.1× 24 496
Amira Kamal El-Hawary Egypt 12 40 0.2× 66 0.6× 41 0.8× 60 1.4× 51 1.3× 38 319
Stefano Monni United States 9 42 0.3× 84 0.7× 23 0.5× 92 2.2× 41 1.0× 20 352
S. Velasco Spain 7 57 0.4× 180 1.6× 21 0.4× 24 0.6× 45 1.1× 9 341
Paulo Guilherme de Oliveira Salles Brazil 11 220 1.4× 192 1.7× 12 0.2× 110 2.6× 92 2.3× 38 390
Hüseyin Astarcıoğlu Türkiye 13 60 0.4× 96 0.8× 16 0.3× 161 3.8× 35 0.9× 33 402
Yoshiaki Yae Japan 10 54 0.3× 100 0.9× 13 0.3× 28 0.7× 11 0.3× 12 491
G. Marzocca Italy 8 154 1.0× 30 0.3× 21 0.4× 91 2.2× 21 0.5× 16 412
Tomoyoshi Inoue Japan 12 36 0.2× 91 0.8× 12 0.2× 65 1.5× 22 0.6× 31 465

Countries citing papers authored by Cameron Marlow

Since Specialization
Citations

This map shows the geographic impact of Cameron Marlow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cameron Marlow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cameron Marlow more than expected).

Fields of papers citing papers by Cameron Marlow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cameron Marlow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cameron Marlow. The network helps show where Cameron Marlow may publish in the future.

Co-authorship network of co-authors of Cameron Marlow

This figure shows the co-authorship network connecting the top 25 collaborators of Cameron Marlow. A scholar is included among the top collaborators of Cameron Marlow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cameron Marlow. Cameron Marlow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Cohen, Steven J., André Konski, Samuel Putnam, et al.. (2014). Phase I study of capecitabine combined with radioembolization using yttrium-90 resin microspheres (SIR-Spheres) in patients with advanced cancer. British Journal of Cancer. 111(2). 265–271. 15 indexed citations
2.
Isharwal, Sumit, Danil V. Makarov, Lori J. Sokoll, et al.. (2011). ProPSA and Diagnostic Biopsy Tissue DNA Content Combination Improves Accuracy to Predict Need for Prostate Cancer Treatment Among Men Enrolled in an Active Surveillance Program. Urology. 77(3). 763.e1–763.e6. 44 indexed citations
3.
Kortenhorst, Madeleine S.Q., Sumit Isharwal, P. J. van Diest, et al.. (2009). Valproic acid causes dose- and time-dependent changes in nuclear structure in prostate cancer cells in vitro and in vivo. Molecular Cancer Therapeutics. 8(4). 802–808. 31 indexed citations
4.
Makarov, Danil V., Sumit Isharwal, Lori J. Sokoll, et al.. (2009). Pro–Prostate-Specific Antigen Measurements in Serum and Tissue Are Associated with Treatment Necessity among Men Enrolled in Expectant Management for Prostate Cancer. Clinical Cancer Research. 15(23). 7316–7321. 44 indexed citations
5.
Isharwal, Sumit, Danil V. Makarov, H. Ballentine Carter, et al.. (2009). DNA content in the diagnostic biopsy for benign‐adjacent and cancer‐tissue areas predicts the need for treatment in men with T1c prostate cancer undergoing surveillance in an expectant management programme. British Journal of Urology. 105(3). 329–333. 11 indexed citations
7.
Kortenhorst, Madeleine S.Q., Sumit Isharwal, Paul van Diest, et al.. (2008). Valproic acid causes dose- and time-dependent changes in nuclear structure in prostate cancer cells in vitro and in vivo. Cancer Research. 68. 2615–2615. 3 indexed citations
8.
Isharwal, Sumit, Michael Craig Miller, Cameron Marlow, et al.. (2008). p300 (histone acetyltransferase) biomarker predicts prostate cancer biochemical recurrence and correlates with changes in epithelia nuclear size and shape. The Prostate. 68(10). 1097–1104. 54 indexed citations
9.
Veltri, Robert W., Michael Craig Miller, Sumit Isharwal, et al.. (2008). Prediction of Prostate-Specific Antigen Recurrence in Men with Long-term Follow-up Postprostatectomy Using Quantitative Nuclear Morphometry. Cancer Epidemiology Biomarkers & Prevention. 17(1). 102–110. 16 indexed citations
10.
Veltri, Robert W., Cameron Marlow, Masood A. Khan, et al.. (2007). Significant variations in nuclear structure occur between and within Gleason grading patterns 3, 4, and 5 determined by digital image analysis. The Prostate. 67(11). 1202–1210. 21 indexed citations
11.
Makarov, Danil V., Cameron Marlow, Jonathan I. Epstein, et al.. (2007). Using nuclear morphometry to predict the need for treatment among men with low grade, low stage prostate cancer enrolled in a program of expectant management with curative intent. The Prostate. 68(2). 183–189. 21 indexed citations
12.
Parwani, Anil V., Cameron Marlow, Angelo M. De Marzo, et al.. (2006). Immunohistochemical Staining of Precursor Forms of Prostate-specific Antigen (proPSA) in Metastatic Prostate Cancer. The American Journal of Surgical Pathology. 30(10). 1231–1236. 11 indexed citations
13.
Veltri, Robert W., Masood A. Khan, Cameron Marlow, et al.. (2006). Alterations in nuclear structure and expression of proPSA predict differences between native Japanese and Japanese-American prostate cancer. Urology. 68(4). 898–904. 8 indexed citations
14.
Shiff, Clive, Robert W. Veltri, Joseph Otchere, et al.. (2006). Ultrasound verification of bladder damage is associated with known biomarkers of bladder cancer in adults chronically infected with Schistosoma haematobium in Ghana. Transactions of the Royal Society of Tropical Medicine and Hygiene. 100(9). 847–854. 55 indexed citations
15.
Veltri, Robert W., et al.. (2006). Nuclear structure by semi-automated Iiage analysis classifies prostate cancer feulgen-stained nuclei captured from gleason graded tissue patterns.. 66. 1240–1241. 3 indexed citations
16.
Lapsley, Marta, et al.. (1991). Beta 2-glycoprotein-1 (apolipoprotein H) excretion in chronic renal tubular disorders: comparison with other protein markers of tubular malfunction.. Journal of Clinical Pathology. 44(10). 812–816. 17 indexed citations
17.
Marlow, Cameron, et al.. (1991). A Sandwich Enzyme-Linked Immunosorbent Assay for β2-Glycoprotein I. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 28(3). 283–289. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026